Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

NCT01991587 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

NCT00125944 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

NCT03927131 ·Status: COMPLETED ·Phase: PHASE3

A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

NCT03450915 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

NCT00903552 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

NCT00192127 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

NCT02015494 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

NCT02233816 ·Status: COMPLETED ·Phase: PHASE2

Influenza Antiviral DAS-181-F04 in Healthy Adults

NCT01651494 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

NCT02247362 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

NCT02307851 ·Status: COMPLETED ·Phase: PHASE2

BPL-1357 Against H1N1 Influenza Virus Challenge

NCT07215858 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

NCT00644059 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

NCT06334510 ·Status: COMPLETED

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

NCT04439695 ·Status: COMPLETED ·Phase: PHASE1

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

NCT02434276 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg

NCT05569239 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05823974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Influenza Antiviral DAS181-F03

NCT01173224 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

NCT03853993 ·Status: COMPLETED ·Phase: PHASE3

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

NCT03789539 ·Status: UNKNOWN ·Phase: PHASE1

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

NCT03969212 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza

NCT03903718 ·Status: WITHDRAWN ·Phase: PHASE2

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

NCT00989287 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine

NCT00873912 ·Status: COMPLETED ·Phase: PHASE4